Search
for
Sort by
Research 901–930 of 1000+
- COVID-19 and hypopituitarism
- Metabolic syndrome — a new definition and management guidelines
- Polycystic ovary syndrome is associated with weight‐loss attempts and perception of overweight independent of BMI: a population‐based cohort study
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature
- Dermatological aspects of gender affirming medical treatment in transgender and gender diverse people: A systematic review
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome
- Omega Fatty Acids in Hair Loss Disorders: A Scoping Review of Preclinical and Clinical Evidence
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Anti-Hair Loss Activity of Healthy Human Scalp-Derived Staphylococcus capitis KMH304 Ferment Filtrate in Human Hair-Follicle Dermal Papilla and Keratinocyte Cells
- Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Development of Ethosomes for the Topical Treatment of Androgenic Alopecia: Ethanol Effect on Dutasteride Targeting to the Hair Follicles
- Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants
- Risk factors and lipid metabolism characteristics of early‐onset male androgenetic alopecia: A pilot study
- Short-Term Clinical Assessment of Treating Female Androgenic Alopecia with Autologous Stem Cells Derived from Human Hair Follicles
- The Transgender: Endocrinological Assessment
- Changes in bone mineral density in women with early-onset androgenetik alopecia and their correlations with hair-loss stages: a cross-sectional study
- Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage
- Cutaneous manifestation of polycystic ovary syndrome
- Formulation and Evaluation of Minoxidil Loaded Submicron Emulsion Based Topical Gel for Treatment of Alopecia
- 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013
- Polycystic ovary syndrome
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Suppression of uterine and placental ferroptosis by N-acetylcysteine in a rat model of polycystic ovary syndrome